Skip to main content
. 2011 Nov 7;17(41):4563–4571. doi: 10.3748/wjg.v17.i41.4563

Table 2.

Survival of hepatocellular carcinoma patients with different alpha fetoprotein levels over two years

Time (mo) Survival rates (%) (dead/alive cases)
< 20 μg/L 20-250 μg/L ≥ 250 μg/L
0 100.0 (0/68) 100.0 (0/36) 100.0 (0/56)
6 95.7 (3/65) 97.2 (1/35)     91.1 (5/51)
12 94.1 (4/64) 97.2 (1/35) 80.4 (11/45)
18 91.2 (6/62) 91.7 (3/33) 73.2 (15/41)
24 86.8 (9/59) 88.9 (4/32) 69.6 (17/39)a
a

P < 0.05 vs serum alpha fetoprotein < 20 μg/L and 20-250 μg/L groups.